Serum biomarker gMS-Classifier2: predicting conversion to clinically definite multiple sclerosis.

Serum biomarker gMS-Classifier2: predicting conversion to clinically definite multiple sclerosis.

<h4>Background</h4>Anti-glycan antibodies can be found in autoimmune diseases. IgM against glycan P63 was identified in clinically isolated syndromes (CIS) and included in gMS-Classifier2, an algorithm designed with the aim of identifying patients at risk of a second demyelinating attack...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: Georgina Arrambide, Carmen Espejo, Jennifer Yarden, Ella Fire, Larissa Spector, Nir Dotan, Avinoam Dukler, Alex Rovira, Xavier Montalban, Mar Tintore
Format: Artikel
Sprache:English
Veröffentlicht: Public Library of Science (PLoS) 2013-01-01
Schriftenreihe:PLoS ONE
Online Zugang:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23555846/pdf/?tool=EBI

Online

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23555846/pdf/?tool=EBI

Ähnliche Einträge